Stock listing

NASDAQ:LYCA Lycia Therapeutics, Inc. Stock

Home listing (NASDAQ) of Lycia Therapeutics, Inc.

Follow Lycia Therapeutics, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:LYCA

$31.35 USD +0.43 (+1.4%)

Close on Nov 18, 2026

Past month +4.5% · daily closes, Oct 23, 2026 – Nov 18, 2026, adjusted for splits
Day range
$30.45 – $32.85 USDNov 18, 2026
Volume
383,616 sharesNov 18, 2026
Market cap
$1.63B USDAt the close on Nov 18, 2026 · price × 52.09M shares outstanding

Prices by listing

ListingLastChangeVolumeOpenHighLowPrevious closePrice from
NASDAQ:LYCA · Home$31.35 USD+0.43 (+1.4%)383,616$30.45$32.85$30.45$30.92Close on Nov 18, 2026

Daily closes

Last 3 months, Oct 23, 2026 – Nov 18, 2026 · NASDAQ:LYCA · USD, adjusted for splits

DayCloseChange%OpenHighLowVolume
$31.35+0.43+1.4%$30.45$32.85$30.45383,616
$30.92+2.31+8.1%$28.62$31.72$28.62496,158
$28.61-2.59-8.3%$31.23$32.40$28.18250,870
$31.20-1.63-5.0%$32.83$33.00$31.20189,539
$32.83+1.39+4.4%$32.00$33.44$30.90496,078
$31.44+0.14+0.4%$31.50$33.56$31.01329,514
$31.30+0.94+3.1%$30.36$31.57$29.88239,518
$30.36-0.14-0.5%$30.35$30.68$28.77184,429
$30.50+1.70+5.9%$28.91$31.18$28.91369,987
$28.80-0.12-0.4%$29.16$29.34$27.94189,794
$28.92+1.32+4.8%$27.48$28.92$26.42302,649
$27.60+0.42+1.5%$26.98$28.03$26.98195,317
$27.18+0.78+3.0%$27.14$27.66$26.01270,514
$26.40-1.33-4.8%$27.17$27.59$25.66202,400
$27.73+2.68+10.7%$25.25$27.83$24.51173,100
$25.05-1.06-4.1%$26.48$26.48$24.03433,100
$26.11-2.74-9.5%$26.51$28.00$24.63426,800
$28.85-1.15-3.8%$23.73$30.91$23.73965,500
$30.00——$28.55$36.49$22.192,284,000
Ticker
NASDAQ:LYCA
Asset type
Stock
Sector
Health care
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

All Lycia Therapeutics, Inc. news

Financings

  • Public offering of shares of common stock

    Oct 26, 2026

    Closed: US$365.1M raised · US$18 a share · Jefferies +4

    Dealers: Jefferies (co-lead), TD Cowen (co-lead), Evercore ISI (co-lead), Guggenheim Securities (co-lead), LifeSci Capital

    Closed Oct 26, 2026

  • Public offering of common stock

    Oct 22, 2026

    Announced: about US$317.5M · US$18 a share · Jefferies +4

    Dealers: Jefferies (co-lead), TD Cowen (co-lead), Evercore ISI (co-lead), Guggenheim Securities (co-lead), LifeSci Capital

    Announced Oct 22, 2026

Read by 6ix AI from the company's releases

Lycia Therapeutics, Inc. on 6ix

Sector
Health care
Industry
Biotechnology
News releases
3 in the last 12 months · 3 in all · newest Nov 11, 2026 · oldest 2026

Where Lycia Therapeutics, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:LYCA · Home listing · This pageNASDAQUnited StatesUSD
BOATS:LYCABOATSUnited StatesUSD

Log in to ask 6ix AI your own questions about Lycia Therapeutics, Inc.